Independent analysis puts a SGN mazdutide lot at 99.2%, against 96.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Coverage naming SGN
Page 2 of 2 of this archive, newest first.
SGN declines, for the 24th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a SGN exenatide lot at 96.4%, against 94.7% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at SGN in October, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at SGN in October, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at SGN in October, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a SGN survodutide lot at 96.5%, against 95.8% on the certificate
The result is unremarkable. What the report omits is not.
What changed at SGN in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a SGN liraglutide lot at 95.7%, against 93.4% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
SGN declines, for the 12th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
SGN declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.